Want to create an interactive transcript for this episode?
Podcast: CME
Episode: The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
Description:
Faculty: prof. Hiddo Heerspink
Faculty: Peter Rossing, MD, DMSc
Faculty: Paola Fioretto, MD
Chronic kidney disease (CKD) is a common complication in type 2 diabetes that is closely linked to cardiovascular risk and often diagnosed late. Early detection with UACR and eGFR, plus treatment with therapies such as SGLT2 inhibitors, finerenone, and GLP-1 receptor agonists, has transformed treatment and guideline recommendations. Attention is now shifting to CKD in type 1 diabetes. Ongoing trials, such as FINE-ONE with finerenone, may soon expand therapeutic options and ensure no patient is left behind.